What is the current valuation of the US wound care-biologics market as of 2024?

The market valuation was $1425.0 Million in 2024. Read More

What is the projected market valuation for the US wound care-biologics market in 2035?

The projected valuation for 2035 is $2917.0 Million. Read More

What is the expected CAGR for the US wound care-biologics market during the forecast period 2025 - 2035?

The expected CAGR during this period is 6.73%. Read More

Which companies are considered key players in the US wound care-biologics market?

Key players include Smith & Nephew, Mölnlycke Health Care, Acelity, 3M, ConvaTec, Medtronic, Organogenesis, Integra LifeSciences, and B. Braun Melsungen AG. Read More

How do collagen-based dressings perform in the US wound care-biologics market?

Collagen-based Dressings had a valuation range of $300.0 Million to $600.0 Million. Read More

What is the market size for chronic wounds in the US wound care-biologics market?

The market size for chronic wounds ranges from $570.0 Million to $1200.0 Million. Read More

Which end users dominate the US wound care-biologics market?

Hospitals dominate the market with a valuation range of $570.0 Million to $1150.0 Million. Read More

What is the valuation range for diabetic foot ulcers in the US wound care-biologics market?

The valuation range for diabetic foot ulcers is $400.0 Million to $800.0 Million. Read More

US Wound Care Biologics Market

Q: What are the main segments of the US wound care-biologics market?

Main segments include Collagen-based Dressings, Skin Substitutes, Growth Factor-based Products, and Hyaluronic Acid Dressings. Read More

Q: What applications are included in the US wound care-biologics market?

Applications include Surgical Application, Burn Treatment, Diabetic Foot Ulcers, and Venous Leg Ulcers. Read More

US Wound Care Biologics Market Research Report By Product Type (Collagen-based Dressings, Skin Substitutes, Growth Factor-based Products, Hyaluronic Acid Dressings), By Wound Type (Acute Wounds, Chronic Wounds, Surgical Wounds, Traumatic Wounds), By End User (Hospitals, Home Healthcare, Long-term Care Facilities, Specialty Clinics) and By Application (Surgical Application, Burn Treatment, Diabetic Foot Ulcers, Venous Leg Ulcers) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.73%

2024 Market Size

$ 1,425 Million

2035 Market Size

$ 2,917 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/13128-HCR | Pages: 100 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Type (USD Million)
  1. 4.1.1 Collagen-based Dressings
  2. 4.1.2 Skin Substitutes
  3. 4.1.3 Growth Factor-based Products
  4. 4.1.4 Hyaluronic Acid Dressings
2. 4.2 Healthcare, BY Wound Type (USD Million)
  1. 4.2.1 Acute Wounds
  2. 4.2.2 Chronic Wounds
  3. 4.2.3 Surgical Wounds
  4. 4.2.4 Traumatic Wounds
3. 4.3 Healthcare, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Home Healthcare
  3. 4.3.3 Long-term Care Facilities
  4. 4.3.4 Specialty Clinics
4. 4.4 Healthcare, BY Application (USD Million)
  1. 4.4.1 Surgical Application
  2. 4.4.2 Burn Treatment
  3. 4.4.3 Diabetic Foot Ulcers
  4. 4.4.4 Venous Leg Ulcers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Smith & Nephew (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Mölnlycke Health Care (SE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Acelity (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 3M (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 ConvaTec (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Medtronic (IE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Organogenesis (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Integra LifeSciences (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 B. Braun Melsungen AG (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY WOUND TYPE
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY TYPE, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY WOUND TYPE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY WOUND TYPE, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY END USER, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY WOUND TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Wound Care Biologics Market Segmentation

US Wound Care Biologics Market By Type (USD Million, 2025-2035)

Collagen-based Dressings
Skin Substitutes
Growth Factor-based Products
Hyaluronic Acid Dressings

US Wound Care Biologics Market By Wound Type (USD Million, 2025-2035)

Acute Wounds
Chronic Wounds
Surgical Wounds
Traumatic Wounds

US Wound Care Biologics Market By End User (USD Million, 2025-2035)

Hospitals
Home US Wound Care Biologics Market
Long-term Care Facilities
Specialty Clinics

US Wound Care Biologics Market By Application (USD Million, 2025-2035)

Surgical Application
Burn Treatment
Diabetic Foot Ulcers
Venous Leg Ulcers

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”